No Data
No Data
Ainos, Inc. Reports Q3 Financial Results and Strategic Developments
Ainos Receives Institutional Review Board Approval From Shuang Ho Hospital For Its Trial Of VELDONA In Sjögren's Syndrome
Ainos Third Quarter 2024 Earnings: US$0.33 Loss per Share (Vs US$0.73 Loss in 3Q 2023)
Express News | Ainos Inc - Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities
Ainos Files Complaints With Nasdaq MarketWatch And The SEC Of Concerns Over Large-Volume Sell Orders, Says It 'Suspects That These Trading Activities May Involve Regulatory Violations'
Ainos Q3 Net Loss $3,699,317
Unlock the Full List